The Current Advancement in Psoriasis

被引:9
作者
Bhagwat, Aishwarya P. [1 ]
Madke, Bhushan [1 ]
机构
[1] Datta Meghe Inst Higher Educ & Res, Jawaharlal Nehru Med Coll, Dermatol, Wardha, India
关键词
factors; irritation; prevalence; itching; scales; skin inflammation; RISK; OBESITY;
D O I
10.7759/cureus.47006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The study on psoriasis disease helps improve the condition and treatment options day by day in dermatology. In the current scenario, research is ongoing to make the best interventions possible for managing the disease. Psoriasis is one of the most common dermatological conditions wherein chronic inflammation of the skin occurs, characterized by the formation of a rash with scaly, itchy patches over the body surface. The condition is mainly related to the immune system wherein epidermal hyperplasia occurs with infiltration of immune cells. Many factors can trigger psoriasis. Environmental, emotional, hereditary, and personal habits are responsible for the conditions. The current research helps to gain a complete understanding, and the basic knowledge of the state with recent advancements in treatment strategies and characteristic features can also be studied. The main aim is to know the disease's primary root cause and management. It involves the main sites of the body. The most commonly affected parts are the scalp, trunks, knees, elbow, and ankle. It is a chronic long-term disease. Sometimes it may be painful. Itching, bleeding, and disturbed sleep patterns are common symptoms. Most commonly involves the upper epidermal surface. The prevalence of the condition has been increased as it is associated with other comorbidities. The main focus of the treatment is to restrict skin cell multiplication and remove scaly surfaces. This review discusses the advancement in the treatment, its initiation, progression, current symptoms, and disease development. The study also includes basic knowledge about the types of psoriatic disease with its specific features and mechanisms.
引用
收藏
页数:9
相关论文
共 50 条
[41]   The association between obesity and efficacy of psoriasis therapies: An expert consensus panel [J].
Burshtein, Joshua ;
Armstrong, April ;
Chow, May ;
Debusk, Lauren ;
Glick, Brad ;
Gottlieb, Alice B. ;
Gold, Linda Stein ;
Korman, Neil J. ;
Lio, Peter ;
Merola, Joseph ;
Rosmarin, David ;
Rosenberg, Angela ;
Van Voorhees, Abby ;
Lebwohl, Mark .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2025, 92 (04) :807-815
[42]   Metabolic syndrome and psoriasis severity in South-East Asian patients: An investigation of potential association using current and chronological assessments [J].
Chularojanamontri, Leena ;
Wongpraparut, Chanisada ;
Silpa-Archa, Narumol ;
Chaweekulrat, Pichanee .
JOURNAL OF DERMATOLOGY, 2016, 43 (12) :1424-1428
[43]   'Upgrading' psoriasis responsibly [J].
Boehncke, Sandra ;
Boehncke, Wolf-Henning .
EXPERIMENTAL DERMATOLOGY, 2014, 23 (10) :710-711
[44]   Psoriasis and Exercise: A Review [J].
Yeroushalmi, Samuel ;
Hakimi, Marwa ;
Chung, Mimi ;
Bartholomew, Erin ;
Bhutani, Tina ;
Liao, Wilson .
PSORIASIS-TARGETS AND THERAPY, 2022, 12 :189-197
[45]   Psoriasis and cardiovascular diseases [J].
Vizzardi, Enrico ;
Raddino, Riccardo ;
Teli, Melissa ;
Gorga, Elio ;
Brambilla, Giulio ;
Dei Cas, Livio .
ACTA CARDIOLOGICA, 2010, 65 (03) :337-340
[46]   Gut Microbiota in Psoriasis [J].
Buhas, Mihaela Cristina ;
Gavrilas, Laura Ioana ;
Candrea, Rares ;
Catinean, Adrian ;
Mocan, Andrei ;
Miere, Doina ;
Tataru, Alexandru .
NUTRIENTS, 2022, 14 (14)
[47]   Metabolic syndrome in psoriasis [J].
Szponar-Bojda, Anna ;
Krasowska, Dorota ;
Pietrzak, Aldona ;
Chodorowska, Grazyna .
POSTEPY DERMATOLOGII I ALERGOLOGII, 2012, 29 (05) :356-362
[48]   Psoriasis and Its Comorbidities [J].
Onumah, Neh ;
Kircik, Leon H. .
JOURNAL OF DRUGS IN DERMATOLOGY, 2012, 11 (05) :S5-S10
[49]   Psoriasis and Metabolic Syndrome [J].
Sales, Rita ;
Torres, Tiago .
ACTA DERMATOVENEROLOGICA CROATICA, 2014, 22 (03) :169-174
[50]   Psoriasis and cardiometabolic disorders [J].
Nowowiejska, Julia ;
Baran, Anna ;
Flisiak, Iwona .
PRZEGLAD DERMATOLOGICZNY, 2020, 107 (06) :508-520